Septerna (SEPN) Receivables - Net (2023 - 2026)

Septerna's (SEPN) quarterly Receivables - Net came in at $10.8 million in Q1 2026, up 4236.8% year-on-year from $250000.0 in Q1 2025, and up 4.69% quarter-over-quarter from $10.4 million in Q4 2025.

Septerna (SEPN) Receivables - Net (2023 - 2026) Analysis & Trends

Septerna's Receivables - Net history runs 4 years deep, the most recent figure standing at $10.8 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 4236.8% year-over-year to $10.8 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 4236.8% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 5956.14% from the prior year.
  • Receivables - Net rose to $10.8 million in Q1 2026 per SEPN's latest filing, from $10.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $22.6 million in Q4 2023 and bottomed at $151000.0 in Q2 2025.
  • The 4-year median for Receivables - Net is $4.4 million (2025), against an average of $6.7 million.
  • Across the five-year window, Receivables - Net slumped 99.24% in 2024 and soared 5956.14% in 2025, its largest moves.
  • Year by year, Receivables - Net stood at $22.6 million in 2023, then slumped by 99.24% to $171000.0 in 2024, then surged by 5956.14% to $10.4 million in 2025, then gained by 4.69% to $10.8 million in 2026.
  • Per Business Quant, the three latest SEPN Receivables - Net figures stand at $10.8 million (Q1 2026), $10.4 million (Q4 2025), and $8.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Septerna 1.50 Bn 1.50 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10.84 Mn
Mar 31, 2026 10.84 Mn
Dec 31, 2025 10.36 Mn
Dec 31, 2025 10.36 Mn
Sep 30, 2025 8.65 Mn
Sep 30, 2025 8.65 Mn
Jun 30, 2025 151,000.00
Jun 30, 2025 151,000.00
Mar 31, 2025 250,000.00
Mar 31, 2025 250,000.00
Dec 31, 2024 171,000.00
Dec 31, 2024 171,000.00
Sep 30, 2024 210,000.00
Sep 30, 2024 210,000.00
Dec 31, 2023 22.63 Mn
Dec 31, 2023 22.63 Mn